Research Brief Updated 2026-07-13

Most Undervalued Biotechnology Stocks 2026

Top undervalued Biotechnology stocks in 2026 ranked by Bayesian DCF implied upside. 13-model institutional-grade analysis updated daily from SEC EDGAR.

44 stocks analyzed 13 models active By CirclFi Research Team

Top 10

Screened from 44 equities.

# Ticker Company Signal QOC Price DCF Upside
1 ACIU AC Immune SA 5.6 $2.45 +142.7%
2 AGEN Agenus Inc. 5.1 $6.12 +66.8%
3 ADMA ADMA Biologics Inc 10.0 $8.97 -11.1%
4 ARCT Arcturus Therapeutics Holdings 7.0 $6.71 -33.9%
5 ARGX argenx SE 2.2 $876.25 -34.3%
6 ANTX AN2 Therapeutics, Inc. 4.4 $4.55 -39.6%
7 ACAD ACADIA Pharmaceuticals Inc. 9.4 $25.50 -40.5%
8 ABCL AbCellera Biologics Inc. 7.1 $6.52 -46.5%
9 ANAB AnaptysBio, Inc. 6.8 $69.81 -48.8%
10 ALT Altimmune, Inc. 5.1 $2.99 -51.6%
11 A••• Aldeyra ••••• •.• $•••.•• ••.•%
12 A••• Abivax ••••• •.• $•••.•• ••.•%
13 A••• Acumen ••••• •.• $•••.•• ••.•%
14 A••• Apogee ••••• •.• $•••.•• ••.•%
15 A••• Adagene ••••• •.• $•••.•• ••.•%
16 A••• Adicet ••••• •.• $•••.•• ••.•%
17 A••• ALX ••••• •.• $•••.•• ••.•%
18 A••• Alector, ••••• •.• $•••.•• ••.•%
19 A••• Annovis ••••• •.• $•••.•• ••.•%
20 A••• Acrivon ••••• •.• $•••.•• ••.•%

You’re seeing 10 of 44 stocks.

Access the complete dataset with 13 institutional-grade models.

Unlock Full Screening — $39/mo

How CirclFi Ranks Biotechnology Stocks

CirclFi analyzes 44 Biotechnology stocks daily using 13 independent models processing SEC EDGAR filings, FRED macro data, and GDELT sentiment.

For Biotechnology stocks, CirclFi adjusts sector-relative benchmarks — comparing margins, capital intensity, and growth rates against Biotechnology industry medians.

Profitability Matrix

ROIC, Gross Margin expansion, and FCF Yield analysis.

Growth Vector

Revenue compounding vs. sector benchmarks.

Stability Index

Altman Z-Score, debt resilience, and earnings variance.

Methodology: DCF Upside

Bayesian DCF with 10,000 Monte Carlo simulations models probability-weighted intrinsic value using posterior distributions of growth rates, margins, and discount rates.

Models: Bayesian DCF, EPV, First Chicago, Markov DDM, ML-RIV, FTNN Topology, and 7 more.

Frequently Asked Questions

What are the most undervalued biotechnology stocks in 2026?

CirclFi identifies the most undervalued biotechnology stocks 2026 using 13 institutional-grade valuation models including Bayesian DCF (10,000 Monte Carlo simulations), EPV (Greenwald framework), and EROIC Spread (McKinsey). Rankings update daily from SEC EDGAR filings. The current top-ranked stock is ACIU (AC Immune SA).

How does CirclFi rank Biotechnology stocks?

Stocks are ranked by DCF Upside derived from CirclFi's proprietary models. Each model independently processes SEC EDGAR financial data (700+ XBRL tags), FRED macroeconomic indicators, and GDELT news sentiment to produce confidence-weighted fair value estimates. The ranking methodology combines multiple valuation approaches — intrinsic, relative, scenario, and ensemble — for maximum robustness.

How often is the most undervalued biotechnology stocks 2026 list updated?

This list is recalculated daily after US market close. Every stock is re-valued through all 13 models using the latest SEC EDGAR filings, market prices, and FRED macroeconomic data. Rankings can change daily as new financial data becomes available or market prices shift relative to fair value estimates.

What is the Quality of Company (QOC) score?

The QOC score is a 0-10 composite rating derived from 32 fundamental signals across four pillars: profitability (ROE, ROIC, margins), growth (revenue CAGR, earnings acceleration), stability (earnings volatility, debt coverage), and capital efficiency (asset turnover, free cash flow yield). Higher scores indicate stronger fundamentals. Scores above 7 represent top-tier companies.

How does this list compare to other stock screeners?

Unlike simple screeners that filter by P/E or dividend yield, CirclFi runs 13 independent institutional-grade valuation models on every stock — including Bayesian DCF with Monte Carlo simulation, Greenwald EPV, and McKinsey economic profit frameworks. Each stock receives over 76,000 data points of analysis daily. Most retail screeners use 1-2 metrics; CirclFi uses 13 models with 32 quality signals.